Monday, September 14, 2026

BTS Jungkook Sets Record on Billboard Hot 100

On the 17th, the U.S. Billboard announced...

Coreline Soft Wins German Lung Cancer Screening Project With 10-Year Long-Term Operating Contract

Coreline Soft is expanding its European AI medical imaging business through a 10-year German lung cancer screening contract, strengthening its position in the growing LDCT screening market.

LG Innotek Targets Flawless AI Vision with Intel-Powered Upgrade

LG Innotek partners with Intel to enhance AI vision inspection, aiming for nearly 100% accuracy in manufacturing processes.

Tag: Lirafugratinib

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

HLB’s Liraglutide: A Game-Changer in Cholangiocarcinoma Treatment with FDA Priority Review

HLB's Elevar Therapeutics receives FDA Priority Review for lirafugratinib, a promising treatment for cholangiocarcinoma with a 47% response rate.

HLB Group Unveils Groundbreaking Cancer Treatments at AACR 2026: What You Need to Know

HLB Group will present key findings on anti-cancer therapies at AACR 2026, highlighting SynKIR-110 and Lirafugratinib's advancements.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.